Brief: Illumina Expands Collaboration With Janssen To Advance Molecular Residual Disease Cancer Test

Illumina

05/01/2024 14:34

Jan 5 (Reuters) - Illumina Inc  ILMN.O :
    * ILLUMINA EXPANDS COLLABORATION WITH JANSSEN TO ADVANCE
MOLECULAR
RESIDUAL DISEASE CANCER TEST
    * INTENDS TO COLLABORATE WITH OTHER LEADERS IN PHARMA TO
HELP
FURTHER DEVELOP AND EXPAND UTILITY OF ITS WGS MRD ASSAY
    * SIGNED AGREEMENT WITH JANSSEN RESEARCH & DEVELOPMENT, LLC

Source text for Eikon:  ID:nPn8xBfSSa 
Further company coverage:  ILMN.O 

 ((Reuters.Briefs@thomsonreuters.com;))